Xin Wang

TL;DR: Haploidentical SCT as upfront therapy was an effective and safe option for SAA patients, with favorable outcomes in experienced centers, and survival outcome for the entire population was significantly adversely associated with increased transfusions and poor performance status pre-SCT.

TL;DR: Haplo‐identical transplantation is a feasible choice for SAA with favourable outcomes and both OS and FFS for the entire population correlated significantly with grades III–IV aGVHD.

TL;DR: Three prominent subtypes of NKTCL are defined, which differ significantly in cell of origin, EBV gene expression, transcriptional signatures, and responses to asparaginase-based regimens and targeted therapy.

TL;DR: It is demonstrated that the combination of RTX and rhTPO significantly increased the CR rate and shortened TTR compared with RTX monotherapy in the treatment of corticosteroid-resistant or relapsed ITP but failed to show a beneficial effect on the long-lasting response.

TL;DR: These findings suggest that MTDH/AEG-1 may be used as a potential biomarker for the diagnosis of cancer, monitoring of cancer progression, and target therapies which may simultaneously inhibit tumor growth, block metastasis, and intensify the efficacy of chemotherapeutic treatments.